NASDAQ: RIGL · Health Care / Biotechnology: Pharmaceutical Preparations

Rigel Pharmaceuticals Inc.

How Rigel Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$961.1M

Price

$51.45

P/E

3.0

EPS (TTM)

$17.23

1-year return

75.0%

Dividend yield

0.0%

52-week range

$43.84–$51.45

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources